Neurologie

De vakgroep neurologie in het ASz bestaat uit onderstaande neurologen. De vakgroep heeft sinds 1994 een perifere deelopleiding.

Naast de assistent in opleiding zijn er meestal 4-5 niet opleidingsassistenten
neurologie aanwezig. Verder bestaat ons team uit twee physician assistants en specialistisch verpleegkundigen (MS, Parkinson, dementie en CVA nazorg). We participeren in de opleiding van
co-assistenten uit het EMC.Op de klinische afdeling in Dordrecht is een stroke unit aanwezig (8 bedden). Twee neurologen participeren actief in het Slaap Waak Centrum. Verder zijn onze aandachtsgebieden cerebrovasculaire ziekten, kinderneurologie, MS, bewegingsstoornissen (Parkinson en botulinetoxine behandelingen) en dementie. Wij hebben een neurovasculaire onderzoekslijn met een promovendus.

Leden

dr. J.W.K. (Janet) de Beukelaar

dr. J.W.K. (Janet) de Beukelaar

Multiple sclerose, neuro-oncologie, KNF

BIG: 69059307101

I.F.M. (Isolde) Evers

I.F.M. (Isolde) Evers

Dementie, extrapiramidale ziekten

BIG: 99062802801

H. (Henk) Kerkhoff

H. (Henk) Kerkhoff

Neuromusculaire ziekten, neurovasculaire ziekten, KNF

BIG: 69021992801

K. (Krista) Kuitwaard

K. (Krista) Kuitwaard

Neuromusculaire aandoeningen, klinische neurofysiologie

BIG: 79059697001

M.A. (Monique) van Rijn

M.A. (Monique) van Rijn

Kinderneurologie, bewegingstoornissen

BIG: 69049336101

dr. D. (Désirée) Zemel

dr. D. (Désirée) Zemel

Multiple sclerose, neuro-oncologie, KNF

BIG: 49046000101

J. (Jeroen) Venhovens

J. (Jeroen) Venhovens

Neurologie

BIG: 79909952401

dr. A.D. (Anouk) Rozeman

dr. A.D. (Anouk) Rozeman

Neurologie, medisch manager vakgroep

BIG: 39909261901

C.V.M. (Constant) Verschuur

C.V.M. (Constant) Verschuur

Neurologie

BIG: 79912217301

dr. D. (Deniz) Güngör

dr. D. (Deniz) Güngör

Neurologie/kinderneurologie

BIG: 09066693701

dr. S.M. (Suzanne) Silvis

dr. S.M. (Suzanne) Silvis

Neurologie

BIG: 19912792501

J. C. (Christine) Verboon

J. C. (Christine) Verboon

Neuroloog

BIG: 59915162001

Dordwijk

Publicaties

01sep

Trigger factors for stroke in young adults: a case-crossover study.

01aug

An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 Cohort.

01jun

Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.

01mei

Medical attention seeking by suspected stroke patients: Emergency medical services or general practitioner?

01feb

Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial.

01jan

Impact of the lockdown on acute stroke treatments during the first surge of the COVID-19 outbreak in the Netherlands.

01dec

Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.

01dec

Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial.

01sep

Optimising Integrated Stroke Care in Regional Networks: A Nationwide Self-Assessment Study in 2012, 2015 and 2019.

01sep

Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.

01sep

Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study.

01aug

Diagnostic performance of an algorithm for automated large vessel occlusion detection on CT angiography.

01jul

Post-SARS-CoV-2-vaccination Cerebral Venous Sinus Thrombosis: an analysis of cases notified to the European Medicines Agency.

01jul

Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.

01jul

Prehospital scales in acute ischaemic stroke management – Authors’ reply.

01mei

Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy.

01mei

Paroxysmal localized Hyperhidrosis, a case-report: When excessive sweating occurs in combination with severe headaches.

01apr

Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial.

01mrt

Comparison of eight prehospital stroke scales to detect intracranial large-vessel occlusion in suspected stroke (PRESTO): a prospective observational study.

01feb

Paroxysmal localized Hyperhidrosis, a case-report: When excessive sweating occurs in combination with severe headaches.

01nov

Diffuse alveolar hemorrhage as an early complication of alemtuzumab treatment: A case report of a multiple sclerosis patient and an overview of 14 cases

01okt

Neurovestibular Dysfunction and Falls in Parkinson’s Disease and Atypical Parkinsonism: A Prospective 1 Year Follow-Up Study

01sep

Randomised trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polradiculoneuropathy.

01jun

Value of Clinical Signs in Identifying Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD).

01jun

Diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy in clinical practice: a survey among Dutch neurologists.

01jun

Risk factors, clinical manifestations and outcome in cerebral venous thrombosis

01jan

Intra-arterial treatment in acute ischemic stroke.

Beeldmateriaal

of login met gebruikersnaam